- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 724
Kytopen sparks $3.6m reaction
Kytopen, the developer of a cell therapy manufacturing platform based on MIT research, has been backed by MIT’s The Engine for a second time.
May 30, 2019Purdue-linked trio pick up funding
Biotech developers Animated Dynamics, Predictive Wear and Brightlamp have all secured commitments worth up to $250,000 from Foundry Investment Fund.
May 30, 2019Vector boxes up $12m
Road freight documentation platform Vector has closed its Congruent Ventures-backed series A at $12m, adding $2m to the initial close reported last month.
May 30, 2019Columbia pumps intellectual property into Tara Biosystems
Columbia University has granted a new licence to its cardiovascular research platform spinout Tara Biosystems, which markets services powered by is "heart-on-a-chip" tissue modelling system.
May 30, 2019Kapost travels to Upland in $45m deal
Salesforce Ventures has exited the content marketing platform in an acquisition by Upland Software that follows some $22m in funding.
May 30, 2019SoFi sorts out another $500m
SoftBank and Renren-backed online financial services provider SoFi is now valued at $4.8bn following a $500m round led by QIA.
May 30, 2019Palo Alto Networks secures Twistlock in $410m acquisition
Dell Technologies Capital will exit container cybersecurity technology provider Twistlock in an acquisition by Palo Alto Networks that follows $63m of funding.
May 30, 2019Avalanche rocks $33m round
Corporate-backed RAM memory product developer Avalanche Technology has now raised more than $100m, its earlier backers including Qualcomm, VTB and Rogers Venture Partners.
May 30, 2019Drawbridge falls to LinkedIn
Mitsui has exited customer data platform developer Drawbridge, which was acquired by LinkedIn after raising a reported $70m in venture capital funding.
May 30, 2019Ayala aligns with corporates for $30m series B
The cancer drug developer has closed a series B round led by development partner Novartis that included Harel Insurance and Finance and SBI JI Innovation Fund.
May 30, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


